Showing results (171-180 of 279) with videos related to
Sort By:
Pageof 28
JNCI Cancer Spectrum|January 24, 2025
Tumor localization strategies of multicancer early detection tests: a quantitative assessmentChristopher Tyson, Kevin H Li, Xiting Cao, et al.Urology|October 31, 2006
Prevalence, severity, and health correlates of lower urinary tract symptoms among older men: the MrOS studyBrent C Taylor, Timothy J Wilt, Howard A Fink, et al.Head & Neck|January 16, 2004
Polymorphisms of GSTT1 and related genes in head and neck cancer riskAdam J Evans, William David Henner, Kristi M Eilers, et al.Urologic Oncology|August 6, 2011
A non-comparative randomized phase II study of 2 doses of ATN-224, a copper/zinc superoxide dismutase inhibitor, in patients with biochemically recurrent hormone-naïve prostate cancerJianqing Lin, Marianna Zahurak, Tomasz M Beer, et al.Cancer|April 23, 2008
C-reactive protein as a prognostic marker for men with androgen-independent prostate cancer: results from the ASCENT trialTomasz M Beer, Alshad S Lalani, Stella Lee, et al.Cancer Chemotherapy and Pharmacology|May 2, 2003
Safety and efficacy of the MDR inhibitor Incel (biricodar, VX-710) in combination with mitoxantrone and prednisone in hormone-refractory prostate cancerRandall P Rago, Albert Einstein, Richard Lush, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 16, 2009
Prostate cancer-associated gene expression alterations determined from needle biopsiesDavid Z Qian, Chung-Ying Huang, Catherine A O'Brien, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 12, 2011
Randomized trial of autologous cellular immunotherapy with sipuleucel-T in androgen-dependent prostate cancerTomasz M Beer, Guy T Bernstein, John M Corman, et al.Journal of the National Comprehensive Cancer Network : JNCCN|August 13, 2018
DNA Repair Gene Alterations and PARP Inhibitor Response in Patients With Metastatic Castration-Resistant Prostate CancerEric Lu, George V Thomas, Yiyi Chen, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 20, 2013
Genetic profiling to determine risk of relapse-free survival in high-risk localized prostate cancerChristine M Barnett, Michael C Heinrich, Jeong Lim, et al.Pageof 28